In just three months, one British research team identified the first life-saving drug of the pandemic (and helped cancel hydroxychloroquine).
Throughout history, US presidents have fudged the truth about their health. But all the data voters need about Trump is already out for everyone to see.
Public health experts think Covid-19 risk is lower outside, and restaurateurs want to fill tables. It’s an easy solution—except for all the hard parts.
Sure, large crowds already carry a risk of transmission. It’s just worse when you teargas people, make them cough on each other, and bus them to jail.
A large, double-blind study examined 821 people who had been exposed to the virus. The drug was no better at stopping Covid-19 infection than a placebo.
As public spaces reopen, scientists are racing to understand the mysterious and turbulent way the disease spreads through air—from person to person, and place to place.
Population density didn’t make Covid-19 worse in New York City. If you want to know what went wrong, you have to think a lot smaller.
An immunization shot is still in development, but debate over who gets priority has already begun.
There’s been a lot of heat but not much light on whether the antimalarial drug helps coronavirus patients. That’s because we still need a big clinical trial.
Scientists have no shortage of contenders to fight the new coronavirus. But to find the winners, they’re trying new approaches to testing.